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Effects of contrast media and mannitol on renal medullary blood flow
and red cell aggregation in the rat kidney. Hemodynamic factors may play
a role in the development of acute renal failure following administration
of contrast media (CM). In this study the effect of intravenous injection of
contrast media and mannitol on red blood cell velocity (VRBc) and red
blood cell aggregation in renal medullary vessels was studied in 58 rats.
Renal medullary blood flow was investigated by a cross-correlation
technique and by a visual aggregation score. The CM, namely diatrizoate,
iopromide, iohexol, ioxaglate, iotrolan, were given in iodine equivalent
doses (1600 mg/kg body wt). Mannitol (950 mOsm/liter) and Ringer's
solution were used as controls. The same vessels were studied 30 minutes
before and 30 minutes after injections. VRBC decreased significantly after
injection of diatrizoate, iopromide, iohexol, iotrolan and mannitol. Ring-
er's solution and ioxaglate did not significantly alter medullary blood flow,
while iotrolan and mannitol caused the largest decreases in All CM
and mannitol caused both red cell aggregation and cessation of blood flow.
The decrease in blood flow and increase in red blood cell aggregation after
injection of CM and mannitol may partly explain the occurrence of
contrast medium-induced acute renal failure.
The mechanisms underlying contrast medium-induced acute
renal failure (CM-ARF) are not clear. Circulatory events in the
rat renal medulla have recently attracted the attention of several
groups in the search for an explanation of CM-ARF. The special
vulnerability of the renal medulla to hypoxia and the documented
ability of CM to reduce renal medullary blood flow justifies this
interest. Reduced blood flow in the renal medulla after CM
injection was demonstrated in rats by Nygren et al in 1988 [1] and
trapping of red blood cells in the rat renal medullary vessels
following injection of CM and mannitol was shown by Nygren in
1989 [2]. More recently Heyman et al [3] observed outer medul-
lary red blood cell trapping and hypoxia following injection of
iothalamate and mannitol. In vivo aggregation of red blood cells
caused by CM and hypertonic solutions has been reported by
several investigators [4—12]. However, the clinical significance of
this phenomenon has been the subject of great controversy
[13—15]. The aim of this investigation was to further examine the
influence of CM on the renal medullary circulation by in vivo
measurement of the red blood cell velocity and the incidence of
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red blood cell aggregation in the medullary vessels after intrave-
nous injection of CM.
The CM investigated were: diatrizoate, ionic ratio 1.5; ioxa-
glate, ionic ratio 3.0; iopromide, non-ionic ratio 3.0; iohexol,
non-ionic ratio 3.0; and iotrolan, non-ionic ratio 6.0 (Table 1).
Methods
Animals
Studies were performed on 58 male Lewis-DA rats with an
average weight of 152 g (SEM 2,5 g). The animals had free access
to tap water and standard chow (R3, Ewos, Södertälje, Sweden;
containing 3 g sodium/kg, 8 g potassium/kg, 21% protein, 13 X 106
Joule/kg) until the day of the experiment. They were anaesthe-
tized with mactin® (Byk-Gulden, Konstanz, Germany), given
intraperitoneally in a dosage of 100 mg/kg body weight (body wt).
Tracheostomy was performed and the rat was placed on a
servo-controlled heating pad to maintain the body temperature at
37.5°C.
Surgical procedures
A polyethylene catheter was placed in the left femoral artery for
blood sampling and monitoring of blood pressure. A fall in
arterial blood pressure below 80mm Hg resulted in termination of
the experiment. The left femoral vein was catheterized for infu-
sion of Ringer's solution (0.5 mI/hr per 100 g body wt) composed
of 120 mtvi NaC1, 2.5 mivi KCI, 25 mM NaHCO3, 0.75 mat CaCI2.
The right femoral vein was catheterized for infusion of CM. The
urinary bladder was catheterized for collection of urine from the
right kidney. The left kidney was exposed by a left subcostal flank
incision and immobilized in a plastic cup. The kidney was embed-
ded in pieces of cotton wool soaked in Ringer's solution. The
renal hilar fat was carefully removed and the renal pelvis was then
opened by an incision to the margin of the renal cortex. This
procedure exposed approximately 1.5 mm of the papilla.
Microscopy
The renal papillary vessels were studied with a Leitz Ortolux
microscope (Leitz, Wetzlar, Germany) and the papilla was trans-
illuminated with an Intralux® 5000 light source (Volpi AG,
Zurich, Switzerland). In addition to direct visual observations with
a microscope, the image was recorded and projected onto a
television screen (Sony PVM-9OCE) by means of a video camera
(Ikegami ITC-410). The final magnification on the television
screen was x640. The information was recorded on videotapes
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Substance
Table 1. Tested subst
Type of contrast
medium
ances
Iodine cone.
mg/mi
Osmolality
mOsm/kg
Diatrizoatea ionic monomer 370 2070
(Urografin®)
lohexola non-ionic monomer 350 783
(Omnipaque®)
Iopromid&' non-ionic monomer 370 774
(Ultravist®)
loxaglatea ionic dimer 320 600
(1-texabrix®)
lotrolana non-ionic dimer 300 320
(Isovist®)
Mannitol — 0 950
Ringer's solution — 0 310
a Data are from the manufacturer
using a videotape recorder (Sony AG-6200) for later off-line
analysis (Fig. 1).
Choice of vessels
In 58 rats, the renal medullary blood flow was studied in a total
of 258 papillary vessels with diameters of 5 to 25 jxm. In each
experiment a good view of the papilla, with as many vessels as
possible in focus, was sought after. Measurements were made on
the visible part of the papilla, as far as possible from the tip, in
order to get as straight vessels as possible to facilitate cross-
correlation measurements. All vasa recta capillaries in the field of
view with a cross-correlation coefficient of 0.3 or better during the
control period were analyzed. Depending on the local anatomy
and optical conditions, it was possible to examine one to nine
vessels in each papilla. To determine the blood vessel width, blood
column diameters were measured from the television screen with
a caliper.
Cross-correlation measurements
Erythrocyte velocities (VRBC) in the vasa recta were deter-
mined off-line from the video recordings using the dual-window
cross-correlation technique based on the method described by
Weyland and Johnson [16] and used on the vasa recta vessels by
Gussis, Jamison and Robertson [17].
The Capi-flow® equipment used for the cross-correlation anal-
yses was supplied by CapiFlow AB (Kista, Sweden). The video
signal was passed through a video photometric analyzer generat-
ing two photometric windows that were displayed on the TV
monitor. These two windows were then positioned along the
monitored vessel. The position of the windows could be manually
adjusted. The velocity of the red blood cells was measured by
continuously computing the transit times between similar optical
signals generated at the two windows by blood cells and plasma
gaps. By dividing the distance between windows by the time delay,
which resulted in maximum cross-correlation, the erythrocyte
velocities were determined. By replaying the videotape and repo-
sitioning the windows, VRBC in several different vessels could be
measured during the same real time. The same vessels were
followed throughout the experiment. The measurements
were performed four times before the CM injection (at —30, —20,
—10 and —3 minutes) and seven times after CM (at +1, +5, +10,
+15, +20, +25 and +28.5 minutes). In all experiments VRBC was
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Fig. 1. Experimental set-up for studying the renal medullaiy vessels in the
papilla.
determined during the first possible 30 seconds within the first two
minutes of each period. With this restriction cross-correlation
measurements could be performed in 91% of the total of 2,838
observation periods.
Aggregation score
To determine the intravascular tendency for red blood cells to
aggregate in the medullary vessels, a simple score method was
used. The blood flow in each vessel with a cross-correlation of 0.3
or better in the field of view was studied throughout the experi-
ment. The control period, before CM or control infusion, was
divided into three 10-minute observation periods. The experimen-
tal period, after CM or control infusion, was divided into six
5-minute observation periods. The blood flow pattern was classed
as (1) normal blood flow, (2) flow with appearance of red blood
cell aggregates, or (3) cessation of flow. The aggregation criterion
was fulfilled when aggregated red cells were seen continuously in
the studied vessel for at least 30 seconds during the observation
period. Analogously, the stop in flow criterion was fulfilled when
flow ceased in the studied vessel for at least 30 consecutive
seconds during the observation period.
Experimental protocol
After the surgical procedures, the animal was allowed to
recover for 45 minutes. The experiment then started with a
30-minute control period followed by a 30-minute period when
CM or control solution was injected intravenously during the first
eight minutes (Fig. 2). Throughout the experiment the blood flow
in the studied medullary vessels was recorded on videotapes. All
CM were given in a dosage of 1600 mg iodine/kg body wt, which
is about 5 ml CM/kg body wt of a 300 mg I/mi CM in a 60 kg
person. Such doses are not unusual in angiographic practice. The
CM tested were: diatrizoate, 370 mg/mI (Urografin®, Schering,
Berlin, Germany); iohexol 350 mg/ml (Omnipaque®, Nycomed
AJS, Oslo, Norway); iopromide, 370 mg/mi (Ultravist®, Seher-
ing); ioxaglate, 320 mg/ml (Hexabrix®, Laboratoire Guerbet,
Aulnay-sous-Bois, France) and iotrolan, 300 mg/mI (Isovist®,
Schering). Mannitol (950 mOsm/kg) or Ringer's solution was used
as a control (Table 1). The dose of control solution infused was 4,5
mi/kg body wt. The amount given ranged from 0.55 to 0.95 ml. All
solutions were at room temperature when administrated.
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Control period Experimental
period
(30 mm) 30 (mm)//////,,,,,Ztt//J,7z_,,,///,,,y/,z/1
_____ ______
Time4 Video tape recording
Intravenous injection
Table 2. Number of experiments, analyzed vessels, vessel diameter and VRBC before and after injection of contrast media, mannitol and Ringer's
solution
Substance
Number of
animals
Number of
analyzed
vessels
Vessel diameter
rna VRBC before CM VROC after CMb Change in VRBC
Diatrizoate 5 27 12.3 0.344 0.230 0.114c
(Urografin) (±0.7) (±0.069) (±0.063) (±0.047)
lohexol 10 39 12.4 0.447 0.320 0.127c
(Omnipaque) (±0.5) (±0.052) (±0.047) (±0.035)
lopromide 9 46 13.6 0.413 0.310 0.102c
(Ultravist®) (±0.5) (±0.051) (±0.046) (±0.035)
loxaglate 9 37 13.6 0.460 0.412 0.049 NS
(Hexabrix®) (±0.7) (±0.053) (±0.048) (±0.036)
lotrolan 9 40 13.2 0.441 0.216 0.225c
(Isovist®) (±0.5) (±0.052) (±0.047) (±0.036)
Mannitol 9 42 14.0
(±0.6)
0.509
(±0.059)
0.346
(±0.047)
0.164c
(±0.035)
Ringer 7 27 13.1
(±1.0)
0.455
(±0.062)
0.462
(±0.056)
—0.007 NS
(±0.042)
NS, Non-significant difference (P > 0.05) compared to the control period.
Data are means SEM.
a Estimated width (see Methods)
bAverage of period +10, +15, +20, +25, +28.5 mm after CM
Significant difference (p < 0.05) compared to the control period
Blood and urine analyses
The urine volumes were measured gravimetrically. The urine
sodium and potassium concentrations (UNa, UK) were measured
by flame photometry (IL 543, Instrumentation Lab., Milano,
Italy). Urine osmolality (U0m) was determined by the freezing
point depression method (Model 3M0; Advanced Instruments,
MA, USA). Two urine samples were collected before CM and
three after CM. Blood samples were taken for hematocrit analysis,
once before and twice after injection of CM.
Statistical evaluation
The data from the measurements of VRBC were analyzed using
a hierarchical repeated measures multivariate analysis of variance
(Manova) model. The GLM procedure [18] was used. The
Manova was followed by univariate tests where appropriate. The
raw data were transformed into percentage change. The analysis
was based on the average percentage change in blood flow in the
four periods before injection of CM as compared to the average in
the five last periods after CM injection (10, 15, 20, 25 and 28.5
mm). The average value from all studied vessels in each animal
was used in the analysis.
The data from the aggregation and cessation of blood flow
observations were analyzed using a repeated measures categorical
data analysis model. The Catmod procedure was used [18]. Before
the analysis the data were converted so that all blood vessels that
displayed any type of reaction (aggregation or cessation of flow)
were coded as 1 (otherwise 0).
The urine excretion and hematocrit data were analyzed by a
Manova model, followed by univariate tests where appropriate.
All statistical evaluation of urine analysis was performed with an
average of the two values before CM compared to the average of
the value from the sampling period after CM with maximal
change. Statistical evaluation of the hematocrit values was per-
formed by comparing the value after CM with maximal change to
the value before CM. A P value < 0.05 was regarded as significant
in all analyses.
Results
Medullaiy blood flow
The average VRBC for all groups before injection was 0.435
(SEM 0.018) mm/sec (Table 2). There was no change in the
blood column diameter of the vessels during the experiments.
Diatrizoate caused a 32% decrease in VRBC, iopromide a 22%
decrease, iohexol a 23% decrease, ioxaglate a 9% decrease,
iotrolan a 47% decrease and mannitol a 32% decrease while
Ringer's solution increased VRBC by 1%. In all groups except for
the ioxaglate and Ringer's groups, VRBC in the medullaly vessels
was significantly decreased (Fig. 3).
Resting period
(45 mm)
t
Operation
Fig. 2. Experimental protocol.
Liss et al: CM and renal medullaty blood flow 1271
Time, minutes
Fig. 3. Relative changes in red blood cell velocity (V) in the renal
medullaiy vessels following intravenous injection of contrast media (CM),
mannitol and Ringer's solution. Symbols are: (•) diatrizoate*; (A) iopro-
mide; (•) iohexol*; () ioxaglate; (0) iotrolan*; () mannitol*; (0)
Ringer's solution. *significant difference (P < 0.05) compared to the
control period.
In all CM groups and in the mannitol group the incidence of red
blood cell aggregation and cessation of blood flow increased
significantly, while no change was found in the Ringer's group.
The incidence of aggregation and flow cessation was significantly
lower after ioxaglate injection than after injection of all other CM
and mannitol. However, the change between the period before
and after CM did not differ significantly between the ioxaglate and
iopromide groups (Fig. 4).
Urine and blood data
Urine flow (UV) increased 7- to 17-fold after injection of
diatrizoate, iohexol, iopromide, ioxaglate or mannitol. Urine flow
after iotrolan injection increased threefold and after Ringer's
1.4-fold (Fig. 5A). The increase in urine flow was significant in all
but the Ringer's group. Urine sodium output (UNaV) increased
three- to 34-fold; the increase was not significant in the iotrolan or
the Ringer's group (Fig. 5C). Urine potassium output (UKV)
increased four- to sixfold in the groups receiving CM and manni-
to!. The increase in urine potassium was significant in all groups
(Fig. SB). Uosm decreased significantly in all groups except the
Ringer's group (Fig. 5D). There was a slight decrease in hemat-
ocrit in all groups; this was significant only in the Ringer's group
(Fig. 5E).
Discussion
In this study, using a cross-correlation technique, we found that
renal medullary VRBC decreased after injection of CM and
mannitol but did not change in animals that received Ringer's
solution and ioxaglate. In the same experiments it was found that
red blood cells had a tendency to aggregate within the medullary
0
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0
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vessels in all the CM groups and in the group injected with
hyperosmolar mannitol. Ringer's solution did not cause a ten-
dency to aggregation. The tendency of red cells to aggregate was
most pronounced after iotrolan and mannitol injection. The
lowest incidence of aggregation caused by CM was seen after
injection of ioxaglate.
Most measurements of renal blood flow have concerned the
total renal blood flow. Our group has previously used a laser
Doppler technique for studies of medullary blood flow after CM
injection [1] and produced results similar to those obtained in the
present study. As the follow-up period after injection of CM was
only 30 minutes in this study, it was not possible to determine
whether acute renal failure would develop in any of the rats.
_____
The reduction in VRBc seen after injection of CM and hyper-
osmolar mannitol might be explained in several ways, for example,
passive compression of the vessels, rheological effects, or a
vasoactive effect on the medullary vessels.
Blood flow may be reduced by compression of the vessels due to
increased tissue pressure in the kidney. Hypertonic CM and
mannitol cause a pronounced osmotic diuresis that distends the
tubules and collecting ducts leading to renal swelling and an
increase in intrarenal venous pressure [19]. The isotonic non-ionic
dimer iotrolan increases the renal interstitial pressure, presum-
ably by another mechanism, as demonstrated by Ueda et al [20,
21]. This CM caused a moderate diuresis compared to that
resulting from low osmolar CM. lotrolan concentrates down-
stream from the tubules, and consequently the intratubular urine
viscosity rises because of the high molecular weight of iotrolan,
resulting in increased intratubular hydrostatic pressure.
Aggregation Aggregation in the medullary vessels, which is most pronounced
with the non-ionic CM and least pronounced with ionic ioxaglate,
changes with papillary blood flow. This suggests that aggregation
may be one of the causes of the observed blood flow decrease.
However, it is a well known fact that aggregation is also observed
in association with a low blood flow [22, 23], which means that the
reverse is just as likely. Aggregation caused by a decrease in shear
rate in a small-caliber vessel will increase the viscosity [24], which
in turn will reduce the blood flow according to Poiseuille's law and
thereby cause further aggregation.
In recent years the effects of CM on blood coagulation mech-
anisms and platelet activity have been thoroughly discussed. In
studies in vitro, ionic CM seemed to inhibit coagulation and
platelet activation to a greater extent than non-ionic CM [25—27].
Some workers have cast doubt on the hypothesis that non-ionic
CM are prothrombotic [28]. Support for the idea of prothrom-
botic activity of non-ionic CM is provided by the findings of
increased coagulation and platelet activity after infusion of non-
ionic CM reported by Hardeman et a! [29, 30].
In the present study, more red blood cell aggregates were found
in the rats receiving non-ionic CM than in those in the ioxaglate
group. The explanation for this finding is unclear, but it is possible
that the negative electric charge of ionic CM molecules leads to
repulsion of the red blood cells and thereby inhibits aggregation.
Although ioxaglate and diatrizoate are both ionic CM, more
aggregates are observed after injection of diatrizoate. This may
indicate that factors other than the electric charge of the CM
molecule are of importance. As the osmotic diuresis and thereby
the interstitial hydrostatic pressure were the same in the groups
that received ionic and non-ionic low osmolar CM, the difference
between these types of CM as far as aggregation tendency and
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VRBC are concerned cannot be explained by intrarenal pressure
differences.
One drawback of the opened pelvis approach to papillary blood
flow measurements is a possible influence on papillary blood flow
as studied by Schmidt-Nielsen et a! [31,32]. They have described
pelvic milking of the urine out of the papilla, a mechanism
postulated to be most important during high urine flows. This
enhancement of urine transport from the collecting ducts may
have secondary effects on blood flow. The possible influence of
this mechanism in the present study cannot be ruled out. How-
ever, we found a smaller decrease in papillary blood flow in the
diatrizoate, injected rats, which had the most pronounced diuresis
(Fig. 5A), than in the iotrolan group (which was the least diuretic
compound tested). These findings indicate that the milking effect
was of minor importance for the present results. This is also
supported by the findings by Lemley et a! [33], who found no
difference in VRBC, measured through an opened pelvis in
anti-diuretic compared to water-diuresis induced rats.
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Fig. 4. Incidence of aggregates of red blood cells
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vessels before and after intravenous contrast
media (CM), mannitol and Ringer's solution.
Symbols are: (El) vessels with aggregates; (•)
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The possible role of vasoactive substances in CM-induced
changes in renal blood flow cannot be ruled out by this study, but
previous work has failed to identify any definite relationship to
renin, angiotensin or prostaglandin systems [34—36].
Only 10 to 15% of the total renal blood flow that passes through
the kidney perfuses the medullary regions [37]. Even major
reductions in renal medullary blood flow are thus not necessarily
reflected in total renal blood flow and the changes in total renal
blood flow are in fact moderate after injection of CM [38—40]. A
reduction in medullary blood flow and aggregation of red blood
cells as observed in the present study may be due to the vascular
architecture of the renal medulla. The counter-current system,
consisting of the ascending and descending vasa recta, builds up
an oxygen gradient in the medulla, with a high P°2 in the outer
part of the medulla and a low P°2 in the inner part. The high 02
requirement for active transport of sodium in the thick ascending
part of the loop of Henle and the collecting ducts makes this
region especially vulnerable to hypoxia [3, 41, 42].
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Agmon et al have reported an increase in outer medullary
blood flow following injection of iothalamate [43]. Our results do
not have to be in conflict with these, as papillary blood flow does
not necessarily reflect flow changes in the whole medulla, as
shown by Agmon et al [43] and Hellberg, Kallskog and Wolgast
[441. On the contrary, many studies have demonstratied outer
medullary trapping of red blood cells in acute renal failure settings
and following administration of contrast media [3, 44, 45]. A
decrease in blood flow can be expected after this trapping. This is
what Hellberg et al [44] found in postischemic kidneys, where
trapping in outer medulla was observed together with a decrease
in the outer medullary blood flow (measured by laser-Doppler).
Different control systems for the outer and inner medulla may
also exist.
The red blood cell aggregation after injection of CM demon-
strated in vivo in other capillary vessels (mesenteric [4, 8, 46], pia
mater, muscle [10], bat wing [11], conjuctival [7, 12]) has been
judged to have no clinical significance [13—15]. Opposing this view
are recent findings by Heyman et al [3] of both trapping of red
blood cells in renal medullary vessels and medullary hypoxia after
CM. The present study demonstrated aggregation of red blood
cells and a decrease in medullary blood flow following injection of
CM and hyperosmolar mannitol, supporting the theory that a
disturbance of renal medullary blood flow is a possible mechanism
underlying CM-ARF.
Conclusions
Contrast media and hypertonic mannitol decrease red blood
cell flow in the rat renal medullary vessels and cause erythrocyte
aggregation, which may contribute to the onset of acute renal
failure following infusions of CM. Non-ionic CM cause more flow
disturbances than ionic ioxaglate.
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